LGNZZ Buybacks
19 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–19; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 2025-12-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2024-12-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2021-12-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2021-03-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2020-12-31 | Reported repurchase cash | $4.71M |
| LIGAND PHARMACEUTICALS INC | 2020-03-31 | Reported repurchase cash | $73.29M |
| LIGAND PHARMACEUTICALS INC | 2019-12-31 | Reported repurchase cash | $81.94M |
| LIGAND PHARMACEUTICALS INC | 2019-03-31 | Reported repurchase cash | $151.59M |
| LIGAND PHARMACEUTICALS INC | 2018-12-31 | Reported repurchase cash | $70.14M |
| LIGAND PHARMACEUTICALS INC | 2018-03-31 | Reported repurchase cash | $1.9M |
| LIGAND PHARMACEUTICALS INC | 2017-12-31 | Reported repurchase cash | $1.97M |
| LIGAND PHARMACEUTICALS INC | 2017-03-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2016-03-31 | Reported repurchase cash | $502,000.00 |
| LIGAND PHARMACEUTICALS INC | 2015-12-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2015-03-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2014-12-31 | Reported repurchase cash | $29.43M |
| LIGAND PHARMACEUTICALS INC | 2013-12-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2011-12-31 | Reported repurchase cash | $0.00 |
| LIGAND PHARMACEUTICALS INC | 2011-03-31 | Reported repurchase cash | $55,000.00 |